[go: up one dir, main page]

MW1291A1 - Medicaments for the treatment of toxo-plasmosis - Google Patents

Medicaments for the treatment of toxo-plasmosis

Info

Publication number
MW1291A1
MW1291A1 MW12/91A MW1291A MW1291A1 MW 1291 A1 MW1291 A1 MW 1291A1 MW 12/91 A MW12/91 A MW 12/91A MW 1291 A MW1291 A MW 1291A MW 1291 A1 MW1291 A1 MW 1291A1
Authority
MW
MALAWI
Prior art keywords
treatment
toxoplasmosis
plasmosis
toxo
medicaments
Prior art date
Application number
MW12/91A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MW1291A1 publication Critical patent/MW1291A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MW12/91A 1989-09-22 1991-05-20 Medicaments for the treatment of toxo-plasmosis MW1291A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898921516A GB8921516D0 (en) 1989-09-22 1989-09-22 Medicaments
PCT/GB1989/001286 WO1991004021A1 (fr) 1989-09-22 1989-10-26 Medicaments pour le traitement de la toxoplasmose

Publications (1)

Publication Number Publication Date
MW1291A1 true MW1291A1 (en) 1991-11-13

Family

ID=10663513

Family Applications (1)

Application Number Title Priority Date Filing Date
MW12/91A MW1291A1 (en) 1989-09-22 1991-05-20 Medicaments for the treatment of toxo-plasmosis

Country Status (17)

Country Link
EP (1) EP0445141B1 (fr)
JP (1) JP2810746B2 (fr)
KR (1) KR920700626A (fr)
AT (1) ATE108063T1 (fr)
AU (1) AU628422B2 (fr)
CA (1) CA2001568C (fr)
DE (1) DE68916651T2 (fr)
DK (1) DK175716B1 (fr)
GB (1) GB8921516D0 (fr)
HU (1) HU207942B (fr)
IE (1) IE66153B1 (fr)
MC (1) MC2142A1 (fr)
MW (1) MW1291A1 (fr)
PH (1) PH27250A (fr)
SG (1) SG28346G (fr)
WO (1) WO1991004021A1 (fr)
ZA (1) ZA898146B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9224739D0 (en) 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
WO2010023686A2 (fr) * 2008-08-29 2010-03-04 Matrix Laboratories Limited Forme cristalline de 2-chloro-3-[4-(4-chlorophényl)cyclohexyl][1,4]naphtoquinone, son procédé et son utilisation pour produire du 2-[4-(4-chlorophényl)cyclohexyl]-3-hydroxy-1,4-naphtoquinone
WO2013093937A2 (fr) * 2011-09-16 2013-06-27 Alkem Laboratories Ltd. Promédicament de ''3-(5-méthyl-2-oxo-l, 3-dioxol-4-yl) méthyloxy-2- trans-[(4-chlorophényl) cyclohexyl] [1,4]naphtaquinone"-atovaquone
CN104474416A (zh) * 2014-11-03 2015-04-01 青岛绿曼生物工程有限公司 治疗猪弓形体病的复方蜂胶组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
IE65715B1 (en) * 1988-08-16 1995-11-15 Wellcome Found Medicaments

Also Published As

Publication number Publication date
JPH04504107A (ja) 1992-07-23
SG28346G (en) 1995-09-18
DK93091A (da) 1991-06-28
DE68916651D1 (de) 1994-08-11
EP0445141A1 (fr) 1991-09-11
CA2001568C (fr) 1998-05-12
MC2142A1 (fr) 1992-02-18
HU896916D0 (en) 1991-08-28
KR920700626A (ko) 1992-08-10
AU628422B2 (en) 1992-09-17
EP0445141B1 (fr) 1994-07-06
ATE108063T1 (de) 1994-07-15
GB8921516D0 (en) 1989-11-08
HUT57040A (en) 1991-11-28
IE66153B1 (en) 1995-12-13
DE68916651T2 (de) 1995-02-16
IE893451A1 (en) 1991-03-27
DK175716B1 (da) 2005-01-31
DK93091D0 (da) 1991-05-16
CA2001568A1 (fr) 1991-03-22
HU207942B (en) 1993-07-28
AU4519189A (en) 1991-04-18
JP2810746B2 (ja) 1998-10-15
ZA898146B (en) 1991-06-26
WO1991004021A1 (fr) 1991-04-04
PH27250A (en) 1993-05-04

Similar Documents

Publication Publication Date Title
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
EP1064000A4 (fr) Vitamine d et ses analogues pour le traitement de tumeurs et d'autres troubles d'hyperproliferation
DE58901401D1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
IT1241997B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
RU98101105A (ru) Новое применение в медицинских целях
ZA898146B (en) Medicaments
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
ZA898143B (en) Medicaments
GB9216859D0 (en) Medicaments
GB9126874D0 (en) Medicaments
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
RU2011380C1 (ru) Способ профилактики и лечения некробактериоза животных
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound